Harry joins Culmination Bio as the Senior Vice President of Business S.

Harry has served in the healthcare industry for over 25 years, primarily in early phase commercialization of therapeutics, molecular diagnostics, and healthcare data. He most recently transitioned from his position serving as the Senior Vice President, Commercial at C2i Genomics.

Harry is excited about the opportunity to work with Culmination Bio, which is at the forefront of unlocking omics-level data to drive precision medicine and accelerate drug discovery and looks forward to contributing to the company's mission.

Outside of Culmination Bio, Harry spends his time exploring the mountains around Salt Lake City snowboarding, mountain biking, and basically trying to be outside with his family.